Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
-
Published:2024-07
Issue:1
Volume:154
Page:184-194
-
ISSN:0091-6749
-
Container-title:Journal of Allergy and Clinical Immunology
-
language:en
-
Short-container-title:Journal of Allergy and Clinical Immunology
Author:
Maurer MarcusORCID, Casale Thomas B., Saini Sarbjit S., Ben-Shoshan Moshe, Giménez-Arnau Ana M., Bernstein Jonathan A., Yagami Akiko, Stjepanovic Aleksandra, Radin Allen, Staudinger Heribert W., Patel Naimish, Amin Nikhil, Akinlade Bolanle, Fan Chunpeng, Bauer Deborah, Yancopoulos George D., Patel Kiran, Mannent Leda P., Laws Elizabeth
Reference41 articles.
1. The classification, pathogenesis, diagnostic workup, and management of urticaria: an update;Maurer;Handb Exp Pharmacol,2022 2. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis;Fricke;Allergy,2020 3. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report;Maurer;Allergy,2011 4. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria;Zuberbier;Allergy,2022 5. Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases;Kolkhir;Nat Rev Immunol,2022
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|